Effects of the New Dual PPARα/δ Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism

Lignende værker

• Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
  af: Cariou, Bertrand, et al.
  Udgivet: (2013)
• The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH model
  af: Liu, Linfu, et al.
  Udgivet: (2020)
• Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
  af: Maltarollo, Vinicius G., et al.
  Udgivet: (2015)
• Distinct but complementary contributions of PPAR isotypes to energy homeostasis
  af: Dubois, Vanessa, et al.
  Udgivet: (2017)
• AMPK and PPARδ agonists are exercise mimetics
  af: Narkar, Vihang A., et al.
  Udgivet: (2008)